You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,004,788


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,004,788
Title:Treatment of ocular neovascularization using anti-VEGF proteins
Abstract: The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase-1 (sFlt-1) protein to the human subject.
Inventor(s): Constable; Ian J. (Mosman Park, AU), Rakoczy; P. Elizabeth (Scarborough, AU), Lai; Chooi-May (Waterford, AU), Chalberg, Jr.; Thomas W. (Redwood City, CA)
Assignee: Avalanche Australia Pty Ltd. (Southbank, AU)
Application Number:15/851,650
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Claims and Patent Landscape of United States Patent 10,004,788

Introduction

When analyzing the claims and patent landscape of a specific patent, such as United States Patent 10,004,788, it is crucial to delve into several key aspects. These include the patent's claims, the legal and regulatory framework, the role of the patent office, and the implications of patent litigation. Here, we will provide a comprehensive and critical analysis of these elements.

The Importance of Patent Claims

Definition and Purpose

Patent claims are the heart of any patent, defining the scope of the invention and the rights granted to the patentee. They determine the patent's potent rights of exclusion, which are essential for protecting the inventor's work[3].

Uncertainty in Claim Interpretation

One of the significant challenges in patent law is the uncertainty surrounding claim interpretation. This uncertainty arises from policy disagreements among judges regarding the proper scope of patent exclusion. Some judges favor narrower patents, while others prefer broader ones, leading to varied case outcomes and unpredictability in the patent system[3].

The Patent Specification and Claims

Written Description and Enablement

The patent specification, as defined by 35 U.S.C. § 112(a)-(b), must include a written description of the invention and instructions on how to make and use it. This quid pro quo is fundamental to the patent system, where the inventor discloses the invention in detail to secure exclusive rights[3].

Claim Construction

Claim construction is a critical phase in patent litigation, where the court interprets the meaning of the claims. The Federal Circuit has established various standards for claim construction, but the process remains complex and often contentious. The lack of clarity on what exactly a patent claim "claims" adds to the confusion, making the system hard to predict and judge-dependent[3].

Legal and Regulatory Framework

Statutory Requirements

For a patent to be valid, it must meet several statutory requirements, including novelty (35 U.S.C. § 102), nonobviousness (35 U.S.C. § 103), and adequate specification (35 U.S.C. § 112). These requirements ensure that the patent covers new and useful inventions that are clearly described and enabled[5].

Role of the Patent Office

The United States Patent and Trademark Office (USPTO) plays a crucial role in evaluating patent applications. The office conducts a first-stage evaluation of patent validity, which can be challenged during litigation. The dual-stage nature of patent-validity analysis means that even if a patent is granted, it can still be found invalid in court[5].

Patent Litigation and Enforcement

Challenges to Patent Validity

Patent litigation often involves challenges to the validity of the patent. These challenges can arise during the initial complaint or as affirmative defenses. For instance, the International Trade Commission (ITC) may review validity challenges when they are brought as defenses, but new challenges raised after a general exclusion order is issued are generally not considered a "changed condition" that would allow the ITC to rescind the order[2].

Joint Inventorship and Contribution

In cases involving multiple inventors, the concept of joint inventorship can be complex. The Federal Circuit has clarified that there is no "explicit lower limit" on the level of inventive contribution required for a finding of co-inventorship. This means that even if an inventor's contribution is not the complete invention, they can still be considered a co-inventor if their contribution was significant and part of a collaborative enterprise[2].

Case Studies and Examples

Self-Anchoring Beverage Containers

The case involving the '850 patent for self-anchoring beverage containers illustrates the complexities of patent litigation. Here, the ITC's authority to adjudicate patent claims was questioned, highlighting the importance of timing and the specific conditions under which validity challenges can be raised[2].

Antibodies and Conjugates

Patents like US 11,066,465 B2, which cover antibodies and conjugates, demonstrate the detailed and technical nature of patent claims. These patents often involve complex biological processes and require precise claim construction to determine their scope and validity[1].

Impact on Business and Innovation

Market Domination

A well-crafted patent with clear and enforceable claims can be a powerful tool for market domination. It allows the patentee to exclude others from making, using, or selling the invention, thereby protecting their market share and innovation[3].

Litigation Costs and Uncertainty

However, the uncertainty and unpredictability in patent claims can lead to high litigation costs and disincentives to settle. This environment can be particularly challenging for small and medium-sized enterprises, which may not have the resources to navigate complex patent litigation[3].

Key Takeaways

  • Clear Claims: Clear and well-defined patent claims are essential for protecting the inventor's rights and ensuring the smooth operation of the patent system.
  • Legal Framework: Understanding the statutory requirements and the role of the USPTO is crucial for navigating the patent landscape.
  • Litigation: Patent litigation can be complex, and challenges to patent validity must be raised under specific conditions.
  • Innovation: A strong patent can be a key factor in market domination, but the costs and uncertainties associated with patent litigation must be carefully managed.

FAQs

What are the key elements of a patent claim?

Patent claims must clearly define the scope of the invention, including what is excluded and what is protected. They must meet the requirements of novelty, nonobviousness, and adequate specification.

How does the USPTO evaluate patent applications?

The USPTO conducts a first-stage evaluation of patent validity, ensuring that the application meets the statutory requirements of novelty, nonobviousness, and adequate specification.

Can new validity challenges be raised after a general exclusion order is issued by the ITC?

Generally, no. New validity challenges raised after a general exclusion order is issued are not considered a "changed condition" that would allow the ITC to rescind the order[2].

What is the significance of joint inventorship in patent law?

Joint inventorship recognizes that multiple individuals can contribute to an invention, even if their contributions are not equal. There is no explicit lower limit on the level of inventive contribution required for a finding of co-inventorship[2].

How do unclear patent claims affect businesses?

Unclear patent claims can lead to high litigation costs, disincentives to settle, and overall uncertainty in the patent system, which can be particularly challenging for small and medium-sized enterprises.

Sources

  1. United States Patent and Trademark Office, US 11,066,465 B2.
  2. Troutman Pepper, Federal Circuit Review - Issue 272.
  3. Cornell Law Faculty Publications, The Unresolved Interpretive Ambiguity of Patent Claims.
  4. Google Patents, Compositions and methods for enhanced gene expression in cone cells.
  5. University of Pennsylvania Law Review, Understanding Patent-Quality Mechanisms.

More… ↓

⤷  Subscribe

Details for Patent 10,004,788

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 June 30, 2006 ⤷  Subscribe 2032-05-15
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 August 10, 2012 ⤷  Subscribe 2032-05-15
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 October 13, 2016 ⤷  Subscribe 2032-05-15
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.